维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Kelly VM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅰ clinical trial of histone deacetylase inhibitor: suberoy lanilide hydroxamic acid administered intravenously显示文摘	Kelly WK Richon VM Connor O	2003	Clin Cancer Res2003，9，10：	1
2	Mild ventrieulomegaly in the fetus, natural history, associated findings and outcome of isolated mild ventriculomegaly : a literature review 显示文摘	Kelly EN Allen VM Seaward G	2001	Prenat Diagn2001，21，8：	1
3	Phase Ⅰ clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously显示文摘	KELLY WK RICHON VM O'CONNOR O	2003	Clin Cancer Res2003，9，101：	1
4	PhaseⅠclinical trial of histone deacetylase inhibitors suberoylanilide hydroxamic acid administered intravenously显示文摘	Kelly WK Richon VM O'Connor O	2003	Clin Lin Cancer Res2003，9，10：	1
5	Histone deacetyIases and cancer: causes and therapies显示文摘	Marks P Rifkind RA Richon VM BresIow R Miller T Kelly WK	2001	Nat Rev Cancer2001，1，3：	1
6	Mild ventriculomegaly in the fetus, natural history, associated findings and outcome of isolated mild ventriculomegaly: a literature review显示文摘	Kelly EN Allen VM Seaward G	2001	Prenat Diagn2001，21，8：	1
7	Analysis of receptor tyrosine kinase ROSl-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion显示文摘	Rimkunas VM Crosby K Kelly M	2012	Clin Cancer Res2012，18，16：	1
8	Singing classes for chronic obstructive pulmonary disease : a randomized controlled trial 显示文摘	Lord VM Hume VJ Kelly JL	2012	BMC Pulm Med2012，12，69：	1
9	Histone deacetylases and cancer: causes and therapies显示文摘	Marks P Rifkind RA Richon VM Breslow R Miller T Kelly WK	2001	Nat Rev Cancer2001，1，3：	1
10	T^annacokinetics andLumor disposition of PECzylaled, methotrexate conjugaled poly-l-lysinedendrimers 显示文摘	Kaminskas LM Kelly BD McLeod VM	2009	Mol Pharm2009，6，4：	1
11	Hybrid total hip arthroplasty: a 7-to 11-year follow up显示文摘	Goldberg VM Ninomiya J Kelly O	1996	Clin Orthop1996，333，：	1
12	Characteri- sation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker显示文摘	KAMINSKAS LM KELLY BD MCLEOD VM	2011	J Control Release2011，152，2：	1
13	Phase Ⅰ clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid ( SAHA ) administered intravenously 显示文摘	Kelly W Richon VM O'Connor O	2003	Clin Cancer Res2003，9，：	1
14	Phase I clinical trial of histone deacetylase inhibitor: saberoylanilide hydroxamic acid administered intravenously 显示文摘	KELLY WK RICHON VM O'CONNOR O	2003	Clin Cancer Res2003，9，101：	1
15	Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer显示文摘	WK Kelly VM Richon O Connor	2003	Cancer Res2003，9，10：	1
16	Histone deacetylase inhibitors:Development as cancer therapy显示文摘	Marks PA Richon VM Kelly WK	2004	Novartis Found Symp2004，259，：	1
17	Hybrid total hip arthoplasty:a 7 to 11 year follow up显示文摘	Goldber VM Ninonmiya J Kelly O	1996	Ctin Orthop1996，333，：	1
18	Mild ventriculomegaly in the fetus, natural history, associated findings and outcome of isolated mild ventriculomegaly: a literature review显示文摘	Kelly EN Allen VM Seaward G	2001	Prenat Diagn2001，21，8：	1
19	Obstetric outcomes in women with multiple sclerosis and epilepsy显示文摘	Kelly VM Nelson LM Chakravarty EF	2009	Neurology2009，73，22：	1
20	Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously显示文摘	Kelly WK Richon VM O'Connor O	2003	Clin Cancer Res2003，9，101：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示